Teradyne (NASDAQ:TER) Stock Rating Lowered by Northland Capmk

Teradyne (NASDAQ:TERGet Free Report) was downgraded by Northland Capmk from a “strong-buy” rating to a “hold” rating in a research report issued to clients and investors on Thursday, Zacks.com reports.

Other analysts also recently issued reports about the stock. Northland Securities downgraded shares of Teradyne from an “outperform” rating to a “market perform” rating and set a $136.00 target price for the company. in a research report on Thursday. JPMorgan Chase & Co. increased their target price on shares of Teradyne from $100.00 to $110.00 and gave the stock a “neutral” rating in a research report on Thursday, April 11th. UBS Group boosted their price target on Teradyne from $130.00 to $170.00 and gave the stock a “buy” rating in a research report on Tuesday, June 18th. Robert W. Baird increased their price objective on Teradyne from $110.00 to $120.00 and gave the company an “outperform” rating in a report on Friday, April 26th. Finally, The Goldman Sachs Group raised their price objective on Teradyne from $118.00 to $161.00 and gave the company a “buy” rating in a research note on Tuesday, May 28th. One research analyst has rated the stock with a sell rating, seven have issued a hold rating and eight have issued a buy rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Hold” and an average target price of $139.64.

Get Our Latest Stock Analysis on TER

Teradyne Price Performance

Teradyne stock opened at $146.42 on Thursday. Teradyne has a fifty-two week low of $81.07 and a fifty-two week high of $163.21. The firm’s 50 day simple moving average is $145.76 and its 200-day simple moving average is $119.96. The company has a market cap of $22.86 billion, a P/E ratio of 55.67, a price-to-earnings-growth ratio of 2.86 and a beta of 1.50.

Teradyne (NASDAQ:TERGet Free Report) last issued its earnings results on Wednesday, April 24th. The company reported $0.51 EPS for the quarter, topping the consensus estimate of $0.33 by $0.18. The business had revenue of $599.82 million during the quarter, compared to analysts’ expectations of $566.31 million. Teradyne had a return on equity of 18.88% and a net margin of 16.15%. Teradyne’s revenue was down 2.9% compared to the same quarter last year. During the same quarter last year, the firm posted $0.55 earnings per share. On average, analysts expect that Teradyne will post 3.05 EPS for the current fiscal year.

Insider Activity at Teradyne

In related news, insider Richard John Burns sold 5,005 shares of the stock in a transaction that occurred on Monday, May 20th. The stock was sold at an average price of $137.64, for a total transaction of $688,888.20. Following the completion of the sale, the insider now directly owns 21,780 shares of the company’s stock, valued at approximately $2,997,799.20. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. In related news, insider Richard John Burns sold 5,005 shares of Teradyne stock in a transaction that occurred on Monday, May 20th. The stock was sold at an average price of $137.64, for a total value of $688,888.20. Following the sale, the insider now owns 21,780 shares of the company’s stock, valued at approximately $2,997,799.20. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Mercedes Johnson sold 625 shares of the business’s stock in a transaction that occurred on Monday, June 3rd. The shares were sold at an average price of $143.84, for a total value of $89,900.00. Following the completion of the sale, the director now owns 18,393 shares in the company, valued at approximately $2,645,649.12. The disclosure for this sale can be found here. Insiders sold a total of 10,005 shares of company stock worth $1,304,763 in the last quarter. Corporate insiders own 0.36% of the company’s stock.

Institutional Trading of Teradyne

A number of large investors have recently added to or reduced their stakes in the company. Mitchell & Pahl Private Wealth LLC boosted its stake in Teradyne by 1.1% in the 2nd quarter. Mitchell & Pahl Private Wealth LLC now owns 7,244 shares of the company’s stock valued at $1,074,000 after purchasing an additional 79 shares during the period. Blair William & Co. IL boosted its stake in shares of Teradyne by 0.6% in the first quarter. Blair William & Co. IL now owns 15,004 shares of the company’s stock valued at $1,693,000 after buying an additional 83 shares during the period. Massmutual Trust Co. FSB ADV grew its position in Teradyne by 17.3% during the second quarter. Massmutual Trust Co. FSB ADV now owns 651 shares of the company’s stock worth $97,000 after buying an additional 96 shares in the last quarter. Quent Capital LLC increased its stake in Teradyne by 6.0% during the 2nd quarter. Quent Capital LLC now owns 1,868 shares of the company’s stock worth $277,000 after acquiring an additional 105 shares during the period. Finally, Benjamin F. Edwards & Company Inc. increased its position in shares of Teradyne by 4.8% in the fourth quarter. Benjamin F. Edwards & Company Inc. now owns 2,346 shares of the company’s stock worth $255,000 after purchasing an additional 107 shares during the period. Institutional investors and hedge funds own 99.77% of the company’s stock.

Teradyne Company Profile

(Get Free Report)

Teradyne, Inc designs, develops, manufactures, and sells automated test systems and robotics products worldwide. It operates through four segments; Semiconductor Test, System Test, Robotics, and Wireless Test. The Semiconductor Test segment offers products and services for wafer level and device package testing of semiconductor devices in automotive, industrial, communications, consumer, smartphones, cloud, computer and electronic game, and other applications.

Featured Articles

Analyst Recommendations for Teradyne (NASDAQ:TER)

Receive News & Ratings for Teradyne Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teradyne and related companies with MarketBeat.com's FREE daily email newsletter.